Literature DB >> 17061049

Inhibition of prostaglandin F(2alpha) by selective cyclooxygenase 2 inhibitors accounts for reduced rat leukocyte migration.

Gustavo Batista de Menezes1, Webster Glayser Pimenta dos Reis, Júlia Maria Moreira Santos, Igor Dimitri Gama Duarte, Janetti Nogueira de Francischi.   

Abstract

To investigate whether selective COX 2 inhibitors (celecoxib, rofecoxib) would play a role in a model of leukocyte migration in rats. Bacterial endotoxin (Escherichia coli LPS) was intraperitoneally injected at time zero in rats that were previously treated with unspecific and selective cyclooxygenase inhibitors. LPS induced a dose and time-dependent increase in leukocyte number, which was predominantly related to the presence of PMN neutrophils. Only rats treated with selective COX 2 inhibitors and indomethacin showed a significant reduction in leukocyte numbers following LPS administration. Prostaglandins E(2) and F(2alpha) were injected into the peritoneum and the chemoatractant effect was studied. Only PGF(2alpha) was able to induce neutrophil increase following injection. Intraperitoneal reposition of PGF(2alpha) restored the abrogated leukocyte response to LPS, shown by rats pretreated with rofecoxib. It can be concluded that COX 2, through PGF(2alpha) release, is the isoform responsible for neutrophil recruitment in the rat model of LPS-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17061049     DOI: 10.1007/s10753-006-9013-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  25 in total

Review 1.  Leukocyte-endothelial cell interactions in the inflammatory response.

Authors:  William A Muller
Journal:  Lab Invest       Date:  2002-05       Impact factor: 5.662

2.  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

Authors:  T D Penning; J J Talley; S R Bertenshaw; J S Carter; P W Collins; S Docter; M J Graneto; L F Lee; J W Malecha; J M Miyashiro; R S Rogers; D J Rogier; S S Yu; E G Burton; J N Cogburn; S A Gregory; C M Koboldt; W E Perkins; K Seibert; A W Veenhuizen; Y Y Zhang; P C Isakson
Journal:  J Med Chem       Date:  1997-04-25       Impact factor: 7.446

3.  COX-2 inhibitors and risk of heart failure.

Authors:  Martin C Kammerl; Jens Debler; Günter A Riegger; Bernhard K Krämer
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

Review 4.  Mechanism of action of aspirin-like drugs.

Authors:  J R Vane; R M Botting
Journal:  Semin Arthritis Rheum       Date:  1997-06       Impact factor: 5.532

Review 5.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

6.  Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis.

Authors:  W Lee; S Aitken; J Sodek; C A McCulloch
Journal:  J Periodontal Res       Date:  1995-01       Impact factor: 4.419

Review 7.  Antipyretics: mechanisms of action and clinical use in fever suppression.

Authors:  D M Aronoff; E G Neilson
Journal:  Am J Med       Date:  2001-09       Impact factor: 4.965

8.  Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

Authors:  C C Chan; S Boyce; C Brideau; S Charleson; W Cromlish; D Ethier; J Evans; A W Ford-Hutchinson; M J Forrest; J Y Gauthier; R Gordon; M Gresser; J Guay; S Kargman; B Kennedy; Y Leblanc; S Leger; J Mancini; G P O'Neill; M Ouellet; D Patrick; M D Percival; H Perrier; P Prasit; I Rodger
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

9.  Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway.

Authors:  Daniela Sachs; Fernando Q Cunha; Sérgio H Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

10.  Participation of the L-arginine-nitric oxide-cyclic GMP-ATP-sensitive K+ channel cascade in the antinociceptive effect of rofecoxib.

Authors:  Myrna Déciga-Campos; Francisco J López-Muñoz
Journal:  Eur J Pharmacol       Date:  2004-01-26       Impact factor: 4.432

View more
  8 in total

Review 1.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

2.  Inhibitory effects of ginger (Zingiber officinale Roscoe) essential oil on leukocyte migration in vivo and in vitro.

Authors:  Gessilda Alcantara Nogueira de Melo; Renata Grespan; Jefferson Pitelli Fonseca; Thiago Oliveira Farinha; Expedito Leite da Silva; Adriano Lopes Romero; Ciomar A Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  J Nat Med       Date:  2010-10-28       Impact factor: 2.343

3.  Leishmania braziliensis prostaglandin F synthase impacts host infection.

Authors:  Eliza Vanessa Carneiro Alves-Ferreira; Tiago Rodrigues Ferreira; Pegine Walrad; Paul M Kaye; Angela Kaysel Cruz
Journal:  Parasit Vectors       Date:  2020-01-08       Impact factor: 3.876

4.  Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.

Authors:  Norbert Degousee; David J Kelvin; Gerd Geisslinger; David M Hwang; Eva Stefanski; Xing-Hua Wang; Ali Danesh; Carlo Angioni; Helmut Schmidt; Thomas F Lindsay; Michael H Gelb; James Bollinger; Christine Payré; Gérard Lambeau; Jonathan P Arm; Armand Keating; Barry B Rubin
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

5.  Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study.

Authors:  Inger Vedin; Tommy Cederholm; Yvonne Freund-Levi; Hans Basun; Erik Hjorth; Gerd Faxén Irving; Maria Eriksdotter-Jönhagen; Marianne Schultzberg; Lars-Olof Wahlund; Jan Palmblad
Journal:  J Lipid Res       Date:  2009-11-24       Impact factor: 5.922

6.  Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

Authors:  C Dianzani; L Brucato; M Gallicchio; A C Rosa; M Collino; R Fantozzi
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

7.  Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2α)-induced luteolysis in the cow.

Authors:  Koumei Shirasuna; Sineenard Jiemtaweeboon; Sybille Raddatz; Akane Nitta; Hans-Joachim Schuberth; Heinrich Bollwein; Takashi Shimizu; Akio Miyamoto
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

8.  Chemical fingerprint, acute oral toxicity and anti-inflammatory activity of the hydroalcoholic extract of leaves from Tocoyena formosa (Cham. & Schlecht.) K. Schum.

Authors:  Francisco Rafael Alves Santana Cesário; Thaís Rodrigues de Albuquerque; Giovana Mendes de Lacerda; Maria Rayane Correia de Oliveira; Bruno Anderson Fernandes da Silva; Lindaiane Bezerra Rodrigues; Anita Oliveira Brito Pereira Bezerra Martins; Jackson Roberto Guedes da Silva Almeida; Mariana Lima Vale; Henrique Douglas Melo Coutinho; Irwin Rose Alencar de Menezes
Journal:  Saudi J Biol Sci       Date:  2018-01-31       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.